Why pharma companies should be allowed to continue to fund medical conferences and doctors' attendance
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2023-01-01
|
| Series: | Journal of Medical Evidence |
| Online Access: | http://www.journaljme.org/article.asp?issn=2667-0720;year=2023;volume=4;issue=3;spage=265;epage=267;aulast=Arora |
| _version_ | 1797231792265101312 |
|---|---|
| author | Anil Arora Ashish Kumar |
| author_facet | Anil Arora Ashish Kumar |
| author_sort | Anil Arora |
| collection | DOAJ |
| first_indexed | 2024-04-24T15:50:00Z |
| format | Article |
| id | doaj.art-283ad0353a8c47daa629b85250bb890a |
| institution | Directory Open Access Journal |
| issn | 2667-0720 2667-0739 |
| language | English |
| last_indexed | 2024-04-24T15:50:00Z |
| publishDate | 2023-01-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Journal of Medical Evidence |
| spelling | doaj.art-283ad0353a8c47daa629b85250bb890a2024-04-01T12:49:00ZengWolters Kluwer Medknow PublicationsJournal of Medical Evidence2667-07202667-07392023-01-014326526710.4103/JME.JME_166_23Why pharma companies should be allowed to continue to fund medical conferences and doctors' attendanceAnil AroraAshish Kumarhttp://www.journaljme.org/article.asp?issn=2667-0720;year=2023;volume=4;issue=3;spage=265;epage=267;aulast=Arora |
| spellingShingle | Anil Arora Ashish Kumar Why pharma companies should be allowed to continue to fund medical conferences and doctors' attendance Journal of Medical Evidence |
| title | Why pharma companies should be allowed to continue to fund medical conferences and doctors' attendance |
| title_full | Why pharma companies should be allowed to continue to fund medical conferences and doctors' attendance |
| title_fullStr | Why pharma companies should be allowed to continue to fund medical conferences and doctors' attendance |
| title_full_unstemmed | Why pharma companies should be allowed to continue to fund medical conferences and doctors' attendance |
| title_short | Why pharma companies should be allowed to continue to fund medical conferences and doctors' attendance |
| title_sort | why pharma companies should be allowed to continue to fund medical conferences and doctors attendance |
| url | http://www.journaljme.org/article.asp?issn=2667-0720;year=2023;volume=4;issue=3;spage=265;epage=267;aulast=Arora |
| work_keys_str_mv | AT anilarora whypharmacompaniesshouldbeallowedtocontinuetofundmedicalconferencesanddoctorsattendance AT ashishkumar whypharmacompaniesshouldbeallowedtocontinuetofundmedicalconferencesanddoctorsattendance |